Order Article Reprints

Byskata K, Lukoseviciute M, Tuti F, Zupancic M, Kostopoulou ON, Holzhauser S, Dalianis T. Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers. 2023; 15(1):93. https://doi.org/10.3390/cancers15010093

Byskata, Karin, Monika Lukoseviciute, Filippo Tuti, Mark Zupancic, Ourania N. Kostopoulou, Stefan Holzhauser, and Tina Dalianis. 2023. "Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited" Cancers 15, no. 1: 93. https://doi.org/10.3390/cancers15010093

Byskata, K., Lukoseviciute, M., Tuti, F., Zupancic, M., Kostopoulou, O. N., Holzhauser, S., & Dalianis, T. (2023). Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers, 15(1), 93. https://doi.org/10.3390/cancers15010093